Unpacking Trump’s healthcare regulatory agenda: Our predictions for rulemaking in the new administration

Explore Trump’s healthcare regulatory agenda, focusing on four key rule-making periods: finalized rules subject to reversal, proposed rules, ongoing models, and future rulemaking.

Kirsta Hackmeier
Kirsta Hackmeier
12 min read

Yesterday, Donald Trump was sworn in as President, marking only the second time in U.S. history that a president will serve two non-consecutive terms (the first was Grover Cleveland in the late 19th century, in case you haven’t read that about a dozen times since the election). This puts Trump in the unusual position of having both a past presidential record to be analyzed and an interest in reshaping the later-term decisions of his predecessor/successor. In today’s blog post, we are going to take advantage of this chronological quirk to explore Trump’s healthcare regulatory agenda, focusing on four key rule-making periods:

  • Recently finalized rules subject to reversal;
  • Proposed rules now inherited by the new administration;
  • Ongoing healthcare models;
  • What new rules to expect in the next four years.

In the first three sections, we’ll take a look at the rules that are most likely to stay, most likely to go, and where there is still quite a bit of uncertainty.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.